NHS England | pharmaphorum

Sunday 24 November 2024

Channels

Content type

Categories

Categories

Sort by

Order

NHS England

News

UK urges Vertex to accept 'generous' Orkambi funding offer

UK urges Vertex to accept 'generous' Orkambi funding offer

Vertex remains at loggerheads with NHS England over funding for Orkambi, but said it would consider the body’s most recent offer of a £500 million, five-year funding deal.

Market Access

Jeremy Hunt NHS Department of Health

Matt Hancock has big shoes to fill as he takes over from Jer...

What changes will the appointment of Matt Hancock MP as Secretary of State for Health and Social Care mean for the NHS?

News

vertex

Fury as NHS rejects cystic fibrosis drug price offer

It may be the 70th birthday of the NHS but this was no day of celebration for a group of patients with cystic fibrosis who have been told by officials there is no way forward in a pricing r

News

Lung Cancer.

Lung cancer drug Keytruda to become routinely available on N...

NICE has given the green light for lung cancer drug Keytruda to be used as a routine treatment for certain patients in England.

Views & Analysis

Perjeta

NHS England takes charge on market access

Today sees patients gain full NHS access to breast cancer drug Perjeta, a full six years on from its initial review by NICE.

Views & Analysis

Broken injection syringe containing uk banknotes over a white background

UK pharma in 2017: NHS funding, a legal challenge and Brexit

The UK pharma industry added its voice to calls for greater NHS funding in 2017 – but Brexit guaranteed there could be no rescue package